Latest in Novartis
Sort by
4 items
-
Novartis Lifts Sales Outlook as it Eyes U.S. Expansion
The pharma company raised its guidance on higher revenue expectations for key treatments and product launches, and is looking at potential mergers and acquisitions for U.S. growth.Business - The Wall Street Journal - 5 days ago -
Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
Schrödinger will receive $150 million upfront plus up to $2.3 billion in milestone and royalty payments.Business - MarketWatch - November 12 -
Novartis Lifts Guidance Again After Key Drugs Help Results
The pharmaceutical giant raised its full-year guidance for the third time this year after higher third-quarter profit and sales topped analysts’ expectations, boosted by revenue from its key drugs.Business - The Wall Street Journal - October 29
